In the News
As published in HealthDay, July 15, 2005.
Cancer Doesn't Have to Cost You Your Fertility
By Amanda Gardner
Cancer treatment advances are giving younger patients the chance to
preserve their fertility, enabling them to start families at a
future date, a new review states.
According to a report in the July/August issue of CA: A Cancer
Journal for Clinicians, physicians can offer an enhanced chance of
protecting fertility without negatively affecting the outcome of
cancer treatment or survival.
"This is very good news because it shows that the number of
people who are being treated with cancer and living, and are able to
be concerned about fertility, is increasing," said Dr. Jay Brooks,
chairman of hematology/oncology at the Ochsner Clinic Foundation in
Baton Rouge, La. "We didn't have this problem years ago because
people didn't live."
According to the review, the last two decades have seen enormous
progress in the five-year survival rates for most cancers.
Simultaneous with this progress has been an improved ability to
preserve fertility without affecting the success of the treatment.
Both radiation and chemotherapy, staples of cancer treatment, can
affect men's and women's ability to have children. In addition,
surgery for testicular or ovarian cancer can diminish or eliminate
the possibility of producing a baby.
For this review, the authors looked at the most common cancers
affecting young adults as well as some less common cancers that
directly affect the reproductive organs. The cancers included
breast, cervical, endometrial, ovarian, and testicular tumors, as
well as leukemia and lymphoma.
"The outlook is much more hopeful because technologies have
improved and we have begun to understand cancer better so we can
offer more conservative therapies," said Dr. Carolyn Runowicz, one
of the review's authors. She is president-elect of the American
Cancer Society and director of the Neag Comprehensive Cancer Center
at the University of Connecticut Health Center in Farmington.
Today, a young woman with ovarian cancer may be able to keep her
uterus and to retain one ovary -- or at least tissue from one ovary.
Older strategies of keeping ovaries in a quiescent phase or
freezing oocytes (eggs) have had only limited success. Newer, more
promising strategies include freezing strips of ovarian tissue, then
reimplanting them after the cancer treatment is completed.
In June, a 28-year-old Israeli woman whose ovaries had been
destroyed by high-dose chemotherapy gave birth to a healthy baby
girl after doctors transplanted some of her own frozen ovarian
tissue. This was the first time such a technique was successful.
"To me, this is very exciting," Runowicz said. "It's still
obviously investigational but it shows a light at the end of the
tunnel."
Cryopreservation (freezing) of semen is recommended for men with
testicular cancer who wish to have children in the future. Although
the procedure and technology are relatively simple, few men take
advantage of this option, the review noted.
"Many times people who are diagnosed with cancer want to get
treated yesterday," Brooks said. "The cancer is so pressing they
don't think about the fertility issues."
Later, however, when the cancer treatment is over, many men (and
women) regain past priorities. By that time, it can be too late.
"Cryopreservation of sperm has been available for a while but
when people hear the word cancer, saving sperm seems like an
unnecessary delay," Runowicz said. "Then, all of sudden when you're
better, they say, 'Gee whiz, I should have done that.'"
"One message for men is cancer doesn't happen like an emergency
and is not an emergency in most cases," Runowicz continued. "They
have time to explore and bring up that subject [sperm preservation]
if the treating physician does not." |